Singlon (montelukast) chewable tablets 5 mg. №28


Manufacturer: Poland



Treatment of bronchial asthma: as an additional treatment for bronchial asthma in patients aged 2-5 years with persistent asthma of mild and moderate severity, which is insufficiently controlled by inhaled corticosteroids, as well as in the case of insufficient control of asthma by short-acting β-agonists; as an alternative treatment that replaces low doses of inhaled corticosteroids in patients 2-5 years of age with persistent mild asthma who have not recently experienced severe asthma attacks, requiring oral corticosteroids, can not use inhaled corticosteroids. Prevention of exercise-induced bronchospasm in patients older than 2 years. Relieving symptoms of seasonal and year-round allergic rhinitis.